[HTML][HTML] Therapeutic potential and limitations of curcumin as antimetastatic agent

P Dytrych, Z Kejík, J Hajduch, R Kaplánek… - Biomedicine & …, 2023 - Elsevier
Abstract Treatment of metastatic cancer is one of the biggest challenges in anticancer
therapy. Curcumin is interesting nature polyphenolic compound with unique biological and …

Modified curcumins as potential drug candidates for breast cancer: An overview

AL Flint, DW Hansen, LVD Brown, LE Stewart, E Ortiz… - Molecules, 2022 - mdpi.com
Breast cancer (BC), the most common malignancy in women, results from significant
alterations in genetic and epigenetic mechanisms that alter multiple signaling pathways in …

Turmeric and curcumin: from traditional to modern medicine

M Akaberi, A Sahebkar, SA Emami - … on Biomarkers and New Targets in …, 2021 - Springer
The rhizome of turmeric (Curcuma longa L.) has been used as an herbal medicine, coloring
agent, spice, and food additive for thousands of years in different parts of the world …

[HTML][HTML] Serum albumin binding studies on antiproliferative cyclic C5-curcuminoid derivatives using spectroscopic methods and molecular modelling

L Tyukodi, BZ Zsidó, C Hetényi, T Kőszegi… - Journal of Molecular …, 2023 - Elsevier
Cyclic C5-curcuminoid derivatives are synthetic analogues of the natural product curcumin
possessing diverse pharmacological potential. We described earlier that some of the cyclic …

Rapid screening of diarylpentanoids from Daphne bholua

SH Dong, MY Lian, JL Han, YF Ai, XF Zhou, M Bai… - Phytochemistry, 2023 - Elsevier
Fractionation motivated by biological activity screening and NMR characteristic signals
analysis led to the isolation of seventeen diarylpentanoids from the whole plant of Daphne …

Curcumin and its new derivatives: Correlation between cytotoxicity against breast cancer cell lines, degradation of PTP1B phosphatase and ROS generation

T Kostrzewa, K Wołosewicz, M Jamrozik… - International Journal of …, 2021 - mdpi.com
Breast cancer is the most common cancer of women—it affects more than 2 million women
worldwide. PTP1B phosphatase can be one of the possible targets for new drugs in breast …

BP-M345 as a Basis for the Discovery of New Diarylpentanoids with Promising Antimitotic Activity

J Moreira, PMA Silva, E Castro, L Saraiva… - International Journal of …, 2024 - mdpi.com
Recently, the diarylpentanoid BP-M345 (5) has been identified as a potent in vitro growth
inhibitor of cancer cells, with a GI50 value between 0.17 and 0.45 µM, showing low toxicity in …

BP-M345, a new diarylpentanoid with promising antimitotic activity

P Novais, PMA Silva, J Moreira, A Palmeira, I Amorim… - Molecules, 2021 - mdpi.com
Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on
human cancer cells. Nevertheless, at that time, the cellular mechanism through which BP …

New diarylpentanoids and chalcones as potential antimicrobial adjuvants

J Moreira, F Durães, J Freitas-Silva… - Bioorganic & Medicinal …, 2022 - Elsevier
Antimicrobial resistance arises due to several adaptation mechanisms, being the
overexpression of efflux pumps (EPs) one of the most worrisome. In bacteria, EPs can also …

Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure–Activity Relationships

J Moreira, L Saraiva, MM Pinto, H Cidade - Molecules, 2022 - mdpi.com
Diarylpentanoids, a class of natural products and their synthetic analogs which are
structurally related to chalcones, have gained increasing attention due to their wide array of …